Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex
Comparison of Smooth Emergence During Extubation After Anesthesia When Sugammadex is Administered Before and After Extubation
1 other identifier
interventional
66
0 countries
N/A
Brief Summary
After surgery is completed under general anesthesia, extubation is performed after recovery from anesthesia, and during this process, bucking, coughing, and rapid and excessive hemodynamic fluctuations occur very often. These phenomena can lead to high intrathoracic pressure, venous congestion, hematoma formation, or increased bleeding after major neck surgery. (1) They can also increase the risk of aerosol generation, which can transmit infection to health care workers. (2) For this, smooth extubation is required. Methods of administering drugs such as lidocaine, opioids, or dexmedetomidine have been proposed for smooth extubation. (3-5) As a disadvantage, the use of these drugs may be associated with deep sedation and reduced airway reflexes . Recently, Babu et al. (6) reported that bucking and coughing during extubation could be reduced by changing the timing of administering a muscle relaxant antagonist rather than using these sedative drugs, and thus complications related to extubation could be reduced. In general, in the awakening process, it was common to administer the muscle relaxant at the point of recovery of spontaneous breathing. However, Babu et al. demonstrated the possibility of safe and smooth extubation by changing the timing of administering neostigmine without the use of sedatives or narcotic analgesics, but there are few studies on sugammadex. Therefore, when recovering from general anesthesia, sugammadex was administered before and immediately after extubation to evaluate and compare smooth extubation (ie, comparison of the frequency of bucking and coughing).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2023
CompletedFirst Posted
Study publicly available on registry
March 2, 2023
CompletedStudy Start
First participant enrolled
October 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2025
CompletedJuly 25, 2024
July 1, 2024
1 year
February 21, 2023
July 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
extubation quality score
score based on the incidence and severity of coughing straining
immediate after extubation
Secondary Outcomes (3)
time to respiration
immediate after extubation
time to extubation
immediate after extubation
sore throat in postanesthetic care unit
in postanesthetic care unit
Study Arms (2)
Control group
NO INTERVENTIONRoutine anesthetic process; sugammadex is administered when spontaneous respiration is returned (before extubation)
Experimental group
EXPERIMENTALsugammadex is administered just after extubation.
Interventions
Eligibility Criteria
You may qualify if:
- patients undergoing general anesthesia for thyroid surgery.
- aged between 19 and 64 years
- American Society of Anesthesiologists physical status I and II
You may not qualify if:
- patients with malformation or tumor of the upper respiratory tract
- patients with risk of aspiration
- obese cases with a BMI \> 35
- patients in which tracheal intubation was difficult
- refusal to participate in research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
February 21, 2023
First Posted
March 2, 2023
Study Start
October 3, 2024
Primary Completion
October 3, 2025
Study Completion
October 3, 2025
Last Updated
July 25, 2024
Record last verified: 2024-07